Growth Metrics

Fennec Pharmaceuticals (FENC) Shareholder's Equity Growth (3y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Fennec Pharmaceuticals 281.48 Mn 244.70 Mn 7.67 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 150.97%
Sep 30, 2025 -53.31%
Jun 30, 2025 -42.17%
Mar 31, 2025 -35.17%
Dec 31, 2024 -33.37%
Sep 30, 2024 -31.46%
Jun 30, 2024 -27.26%
Mar 31, 2024 -50.55%
Dec 31, 2023 -33.88%
Sep 30, 2023 -32.72%
Jun 30, 2023 -31.41%
Mar 31, 2023 -42.07%
Dec 31, 2022 -30.38%
Sep 30, 2022 -42.84%
Jun 30, 2022 -19.67%
Mar 31, 2022 -13.28%
Dec 31, 2021 -9.55%
Sep 30, 2021 -5.96%
Jun 30, 2021 -3.58%
Mar 31, 2021 -0.96%
Dec 31, 2020 2.80%
Sep 30, 2020 52.13%
Jun 30, 2020 55.12%
Mar 31, 2020 43.54%
Dec 31, 2019 49.28%
Sep 30, 2019 52.62%
Jun 30, 2019 52.42%
Mar 31, 2019 329.15%
Dec 31, 2018 238.81%
Sep 30, 2018 182.03%
Jun 30, 2018 181.70%
Mar 31, 2018 214.37%
Dec 31, 2017 252.09%
Sep 30, 2017 68.03%
Jun 30, 2017 59.76%
Mar 31, 2017 38.56%
Dec 31, 2016 64.53%
Sep 30, 2016 44.59%
Jun 30, 2016 57.62%
Mar 31, 2016 26.55%
Dec 31, 2015 28.27%
Sep 30, 2015 -7.42%
Jun 30, 2015 -18.38%
Mar 31, 2015 -31.72%
Dec 31, 2014 92.27%
Sep 30, 2014 4.19%
Jun 30, 2014 -89.55%
Mar 31, 2014 -148.33%
Dec 31, 2013 33.40%